Differential Diagnosis for Preeclampsia: A Comprehensive Guide

Hypertensive disorders in pregnancy remain a significant contributor to maternal and perinatal morbidity and mortality worldwide. Preeclampsia, characterized by new-onset hypertension and often proteinuria after 20 weeks of gestation, is a condition that exists on a spectrum. It can progress from gestational hypertension to severe preeclampsia, eclampsia, and HELLP syndrome if not promptly identified and managed. Accurate diagnosis is paramount, but preeclampsia can mimic other conditions, necessitating a robust differential diagnosis approach. This article delves into the differential diagnosis of preeclampsia, ensuring clinicians can effectively distinguish it from other similar presentations and provide optimal patient care.

Introduction

Preeclampsia, affecting 2% to 8% of pregnancies, is a serious complication demanding vigilant monitoring and timely intervention. While the classical presentation involves hypertension and proteinuria, the clinical picture can be varied. The diagnostic criteria have evolved to recognize that preeclampsia can manifest with hypertension and organ dysfunction beyond proteinuria, including renal, hepatic, neurologic, hematologic, or uteroplacental compromise. Early recognition is vital, but the overlapping symptoms with other conditions require a thorough understanding of the differential diagnoses. This article aims to provide a detailed exploration of conditions that can mimic preeclampsia, aiding healthcare professionals in accurate and timely diagnosis.

Image alt text: A healthcare provider measures the blood pressure of a pregnant woman during a prenatal checkup, emphasizing the importance of monitoring blood pressure in pregnancy to detect conditions like preeclampsia.

Understanding Preeclampsia: Key Features

Before discussing the differential diagnosis, it’s crucial to reiterate the defining features of preeclampsia. Preeclampsia is typically diagnosed after 20 weeks of gestation and is characterized by:

• New-onset Hypertension: Systolic blood pressure (SBP) ≥140 mm Hg or diastolic blood pressure (DBP) ≥90 mm Hg on two occasions at least 4 hours apart, or severe range hypertension (SBP ≥160 mm Hg or DBP ≥110 mm Hg) within a shorter interval.
• Proteinuria: ≥300 mg in a 24-hour urine collection, or a urine protein to creatinine ratio ≥0.3, or urine dipstick ≥2+ if other methods are unavailable.

However, in the absence of proteinuria, preeclampsia can still be diagnosed if new-onset hypertension is accompanied by any of the following new-onset conditions:

• Thrombocytopenia (platelet count <100,000/μL)
• Renal insufficiency (serum creatinine >1.1 mg/dL or doubling of serum creatinine in the absence of other renal disease)
• Impaired liver function (elevated blood concentrations of liver transaminases to twice the upper limit of normal)
• Pulmonary edema
• New-onset cerebral or visual disturbances

These criteria help define preeclampsia, but several other conditions can present with similar signs and symptoms, leading to potential diagnostic confusion.

Differential Diagnoses of Preeclampsia

The differential diagnosis for preeclampsia is broad and includes conditions that can present with hypertension, proteinuria, edema, and other systemic symptoms during pregnancy or postpartum. Key conditions to consider include:

1. Gestational Hypertension

Gestational hypertension, also known as pregnancy-induced hypertension, is defined as new-onset hypertension without proteinuria or other signs of end-organ damage, occurring after 20 weeks of gestation.

• Similarities to Preeclampsia: Both conditions involve new-onset hypertension after 20 weeks of gestation.
• Differences from Preeclampsia: Gestational hypertension lacks proteinuria and the systemic features of preeclampsia (thrombocytopenia, renal insufficiency, liver impairment, pulmonary edema, or neurological symptoms).
• Differentiation: Close monitoring for proteinuria and other signs of preeclampsia is crucial in patients diagnosed with gestational hypertension. If proteinuria or other concerning symptoms develop, the diagnosis should be revised to preeclampsia.

2. Chronic Hypertension

Chronic hypertension is hypertension that is present before pregnancy or diagnosed before 20 weeks of gestation.

• Similarities to Preeclampsia: Both conditions involve hypertension in pregnancy.
• Differences from Preeclampsia: Chronic hypertension is present before pregnancy or early in gestation, while preeclampsia develops after 20 weeks. Chronic hypertension can also be complicated by superimposed preeclampsia.
• Differentiation: History is key to differentiating these conditions. Early prenatal visits and blood pressure measurements help identify pre-existing hypertension. However, women with chronic hypertension can develop superimposed preeclampsia, indicated by a sudden increase in blood pressure, new-onset proteinuria, or worsening end-organ function after 20 weeks.

3. Chronic Renal Disease

Pre-existing renal disease can manifest with hypertension and proteinuria, mimicking preeclampsia.

• Similarities to Preeclampsia: Both can present with hypertension and proteinuria during pregnancy.
• Differences from Preeclampsia: Chronic renal disease is present before pregnancy. Proteinuria and hypertension may be present from early pregnancy.
• Differentiation: A history of renal disease, abnormal renal function tests early in pregnancy, and persistent proteinuria from the first trimester suggest chronic renal disease. However, similar to chronic hypertension, women with chronic renal disease can also develop superimposed preeclampsia.

4. Antiphospholipid Antibody Syndrome (APS)

APS is an autoimmune disorder characterized by blood clots and pregnancy complications, and it can be associated with hypertension and proteinuria.

• Similarities to Preeclampsia: APS can present with hypertension, proteinuria, and thrombocytopenia, overlapping with preeclampsia.
• Differences from Preeclampsia: APS is an autoimmune condition with specific laboratory findings (antiphospholipid antibodies). It can cause recurrent pregnancy loss, thrombosis, and may present earlier in pregnancy or even before pregnancy.
• Differentiation: Consider APS in women with a history of recurrent pregnancy loss, unexplained thrombosis, or known autoimmune disorders. Diagnostic testing for antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies, anti-β2 glycoprotein-I antibodies) is essential.

Image alt text: Blood sample tubes are prepared for laboratory analysis to detect antiphospholipid antibodies, crucial for differentiating antiphospholipid syndrome from preeclampsia in pregnant women with overlapping symptoms.

5. Thrombotic Microangiopathies (TMAs)

TMAs, such as thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), are characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage. HELLP syndrome, a severe form of preeclampsia, is also a TMA, but other TMAs need to be considered in the differential.

• Similarities to Preeclampsia: TMAs can present with hypertension, thrombocytopenia, and renal dysfunction, similar to severe preeclampsia and HELLP syndrome.
• Differences from Preeclampsia: Other TMAs like TTP and HUS are not specific to pregnancy, although pregnancy can trigger them. They often involve more pronounced microangiopathic hemolytic anemia (schistocytes on peripheral smear) and may have different triggers and management.
• Differentiation: Peripheral blood smear to look for schistocytes (fragmented red blood cells) is crucial in differentiating TMAs. ADAMTS13 activity levels can help diagnose TTP. Clinical context and other organ involvement can also help distinguish these conditions.

6. Systemic Lupus Erythematosus (SLE)

SLE, another autoimmune disease, can flare during pregnancy and cause hypertension, proteinuria, and thrombocytopenia, mimicking preeclampsia. Lupus nephritis can specifically cause renal involvement with proteinuria and hypertension.

• Similarities to Preeclampsia: SLE can present with hypertension, proteinuria, thrombocytopenia, and renal dysfunction, overlapping significantly with preeclampsia.
• Differences from Preeclampsia: SLE is a chronic autoimmune disease with systemic involvement beyond pregnancy. Pre-existing SLE or a lupus flare during pregnancy can present with these symptoms.
• Differentiation: History of SLE or other autoimmune diseases is important. Serological markers for SLE (ANA, anti-dsDNA, anti-Sm antibodies, low complement levels) can aid in diagnosis. Differentiating a lupus flare from superimposed preeclampsia can be challenging and may require close monitoring and expert consultation.

7. Epilepsy or Seizure Disorder

Eclampsia, seizures in the context of preeclampsia, must be differentiated from pre-existing epilepsy or other seizure disorders.

• Similarities to Preeclampsia: Eclampsia involves seizures, which can resemble seizures from other causes.
• Differences from Preeclampsia: Eclampsia is associated with hypertension and other features of preeclampsia. Epilepsy is a chronic neurological condition characterized by recurrent seizures, not necessarily related to pregnancy-induced hypertension.
• Differentiation: History of epilepsy or seizure disorder is critical. In eclampsia, seizures are usually preceded or accompanied by signs of preeclampsia (hypertension, proteinuria, etc.). However, eclampsia can occur postpartum, and seizures can be the first presenting sign of preeclampsia. If there is no prior history of seizures, new-onset seizures in pregnancy or postpartum in the context of hypertension should be considered eclampsia until proven otherwise.

8. Pheochromocytoma

Pheochromocytoma, a rare tumor of the adrenal gland that produces catecholamines, can cause paroxysmal hypertension, which may be mistaken for preeclampsia, particularly if it presents with proteinuria (due to hypertensive nephropathy).

• Similarities to Preeclampsia: Pheochromocytoma can cause severe hypertension and potentially proteinuria.
• Differences from Preeclampsia: Pheochromocytoma typically presents with episodic hypertension, often accompanied by headaches, sweating, palpitations, and anxiety. These symptoms may be less typical of preeclampsia.
• Differentiation: Consider pheochromocytoma in women with paroxysmal hypertension, especially if accompanied by classic symptoms like headaches, sweating, and palpitations. Biochemical testing for catecholamines and metanephrines in urine or plasma is diagnostic.

9. Hyperthyroidism

Severe hyperthyroidism (thyroid storm) can present with hypertension, tachycardia, and agitation, which might be confused with severe preeclampsia, especially if proteinuria is also present (due to renal effects of severe illness).

• Similarities to Preeclampsia: Hyperthyroidism can cause hypertension and tachycardia.
• Differences from Preeclampsia: Hyperthyroidism has other characteristic symptoms like heat intolerance, tremor, and goiter. Thyroid function tests are abnormal.
• Differentiation: Assess for signs and symptoms of hyperthyroidism. Check thyroid function tests (TSH, free T4, free T3). Thyroid storm is a medical emergency requiring different management than preeclampsia.

10. Other Medical Conditions

Other conditions, such as primary aldosteronism, Cushing’s syndrome, and coarctation of the aorta, can cause hypertension and should be considered in the differential diagnosis of hypertension in pregnancy, although they less commonly mimic the full spectrum of preeclampsia.

Diagnostic Approach to Differential Diagnosis

When evaluating a pregnant patient with suspected preeclampsia, a systematic approach to differential diagnosis is essential:

1. Detailed History: Obtain a thorough medical history, including:

   • Past medical history: Pre-existing hypertension, renal disease, autoimmune disorders, epilepsy, thyroid disease, history of thrombosis or recurrent pregnancy loss.
   • Obstetric history: History of gestational hypertension or preeclampsia in previous pregnancies.
   • Current pregnancy history: Gestational age, onset and duration of symptoms.
   • Symptoms: Headache, visual changes, abdominal pain, edema, palpitations, seizures, etc.

2. Physical Examination: Perform a complete physical examination, including:

   • Blood pressure measurement (repeated measurements).
   • Assessment of edema (distribution and severity).
   • Neurological exam (reflexes, mental status).
   • Fundoscopic exam (if indicated for severe hypertension).
   • Auscultation of lungs (for pulmonary edema).
   • Palpation of abdomen (epigastric or RUQ tenderness).
   • Thyroid exam (for goiter).

3. Laboratory Investigations: Order appropriate laboratory tests:

   • Urinalysis (proteinuria).
   • Complete blood count (platelets, hematocrit – for hemolysis).
   • Liver function tests (AST, ALT).
   • Renal function tests (serum creatinine, BUN, uric acid).
   • Peripheral blood smear (schistocytes – if TMA suspected).
   • Coagulation studies (PT, PTT, fibrinogen).
   • Antiphospholipid antibodies (if APS suspected).
   • Thyroid function tests (TSH, free T4, free T3 – if hyperthyroidism suspected).
   • 24-hour urine collection for protein (if quantitative proteinuria needed).
   • Urine protein-to-creatinine ratio (for rapid assessment of proteinuria).
   • Consider catecholamines and metanephrines (if pheochromocytoma suspected).

4. Clinical Context and Judgment: Integrate all clinical information, including history, physical exam, and lab results, to arrive at the most accurate diagnosis. Consider the gestational age, severity of symptoms, and risk factors.

5. Consultation: In complex cases or when the diagnosis is unclear, consult with specialists such as maternal-fetal medicine specialists, nephrologists, rheumatologists, or endocrinologists.

Conclusion

Accurate diagnosis of preeclampsia is critical for timely and appropriate management to reduce maternal and fetal complications. However, preeclampsia shares overlapping features with several other conditions, necessitating a thorough differential diagnosis approach. By systematically considering gestational hypertension, chronic hypertension, chronic renal disease, APS, TMAs, SLE, epilepsy, pheochromocytoma, hyperthyroidism, and other relevant medical conditions, clinicians can refine their diagnostic accuracy. A detailed history, comprehensive physical examination, appropriate laboratory investigations, and careful clinical judgment are essential tools in effectively differentiating preeclampsia and ensuring optimal care for pregnant women. Prompt and accurate diagnosis, followed by evidence-based management strategies, remains the cornerstone of improving outcomes in hypertensive disorders of pregnancy.

References

1. Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022 Feb;226(2S):S786-S803.
2. Macedo TCC, Montagna E, Trevisan CM, et al. Prevalence of preeclampsia and eclampsia in adolescent pregnancy: A systematic review and meta-analysis of 291,247 adolescents worldwide since 1969. Eur J Obstet Gynecol Reprod Biol. 2020 May;248:177-186.
3. Battarbee AN, Sinkey RG, Harper LM, Oparil S, Tita ATN. Chronic hypertension in pregnancy. Am J Obstet Gynecol. 2020 Jun;222(6):532-541.
4. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237-e260.
5. Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008 Feb;26(2):295-302.
6. Tanner MS, Davey MA, Mol BW, Rolnik DL. The evolution of the diagnostic criteria of preeclampsia-eclampsia. Am J Obstet Gynecol. 2022 Feb;226(2S):S835-S843.
7. Reddy M, Fenn S, Rolnik DL, et al. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2021 Feb;224(2):217.e1-217.e11.
8. Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019 May;15(5):275-289.
9. Jung E, Romero R, Yeo L, et al. The etiology of preeclampsia. Am J Obstet Gynecol. 2022 Feb;226(2S):S844-S866.
10. BERGER M, CAVANAGH D. TOXEMIA OF PREGNANCY. THE HYPERTENSIVE EFFECT OF ACUTE EXPERIMENTAL PLACENTAL ISCHEMIA. Am J Obstet Gynecol. 1963 Oct 01;87:293-305.
11. Labarrere CA, DiCarlo HL, Bammerlin E, et al. Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. Am J Obstet Gynecol. 2017 Mar;216(3):287.e1-287.e16.
12. Staff AC, Johnsen GM, Dechend R, Redman CWG. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol. 2014 Mar;101-102:120-126.
13. McMaster-Fay RA. Failure of physiologic transformation of the spiral arteries of the uteroplacental circulation in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2004 Nov;191(5):1837-8; author reply 1838-9.
14. Mlambo ZP, Khaliq OP, Moodley J, Naicker T. Circulatory and Placental Expression of Soluble Fms-like Tyrosine Kinase- 1 and Placental Growth Factor in HIV-infected Preeclampsia. Curr Hypertens Rev. 2023;19(1):27-33.
15. Young J. The Etiology of Eclampsia and Albuminuria and Their Relation to Accidental Hæmorrhage. Trans Edinb Obstet Soc. 1914;39:153-202.
16. De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol. 1975 Sep 15;123(2):164-74.
17. Gallo DM, Poon LC, Akolekar R, Syngelaki A, Nicolaides KH. Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks’ gestation. Fetal Diagn Ther. 2013;34(4):241-7.
18. Miller EC, Wilczek A, Bello NA, Tom S, Wapner R, Suh Y. Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics. Ageing Res Rev. 2022 Jan;73:101535.
19. Wheeler SM, Myers SO, Swamy GK, Myers ER. Estimated Prevalence of Risk Factors for Preeclampsia Among Individuals Giving Birth in the US in 2019. JAMA Netw Open. 2022 Jan 04;5(1):e2142343.
20. Shi P, Zhao L, Yu S, Zhou J, Li J, Zhang N, Xing B, Cui X, Yang S. Differences in epidemiology of patients with preeclampsia between China and the US (Review). Exp Ther Med. 2021 Sep;22(3):1012.
21. Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095.
22. Fasanya HO, Hsiao CJ, Armstrong-Sylvester KR, Beal SG. A Critical Review on the Use of Race in Understanding Racial Disparities in Preeclampsia. J Appl Lab Med. 2021 Jan 12;6(1):247-256.
23. Chu H, Ramola R, Jain S, Haas DM, Natarajan S, Radivojac P. Using Association Rules to Understand the Risk of Adverse Pregnancy Outcomes in a Diverse Population. Pac Symp Biocomput. 2023;28:209-220.
24. Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Netw Open. 2021 May 03;4(5):e218401.
25. Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986 Nov;155(5):1011-6.
26. Thoma ME, Boulet S, Martin JA, Kissin D. Births resulting from assisted reproductive technology: comparing birth certificate and National ART Surveillance System Data, 2011. Natl Vital Stat Rep. 2014 Dec 10;63(8):1-11.
27. Nirupama R, Divyashree S, Janhavi P, Muthukumar SP, Ravindra PV. Preeclampsia: Pathophysiology and management. J Gynecol Obstet Hum Reprod. 2021 Feb;50(2):101975.
28. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006 Jan;27(1):56-61.
29. Dionisio LM, Favero GM. Platelet indices and angiogenesis markers in hypertensive disorders of pregnancy. Int J Lab Hematol. 2024 Apr;46(2):259-265.
30. Dankó I, Kelemen E, Tankó A, Cserni G. Correlations of Placental Histopathology, Neonatal Outcome, and Cardiotocogram Baseline Variability and Acceleration Patterns in the Growth Restricted Preterm Population. Pediatr Dev Pathol. 2023 Sep-Oct;26(5):447-457.
31. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013 May;20(3):229-39.
32. Vigil-De Gracia P, Lasso M, Ruiz E, et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):157-62.
33. Xu B, Charlton F, Makris A, Hennessy A. Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro. J Hypertens. 2014 May;32(5):1075-83; discussion 1083.
34. Magley M, Hinson MR. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Oct 6, 2024. Eclampsia.
35. Fu J, Li C, Gou W, Lee A, Li X, Chen Q. Expectant or outpatient management of preeclampsia before 34 weeks: safe for mother but associated with increased stillbirth risk. J Hum Hypertens. 2019 Sep;33(9):664-670.
36. Duvekot JJ, Duijnhoven RG, van Horen E, et al. Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial. Acta Obstet Gynecol Scand. 2021 Jan;100(1):109-118.
37. Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and Current Clinical Management of Preeclampsia. Curr Hypertens Rep. 2017 Aug;19(8):61.